WG
ORGO icon

Winton Group’s Organogenesis Holdings ORGO Stock Holding History

Winton Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,945
Closed -$54.2K – 740
2024
Q3 		$54.2K Sell
18,945
-42,121
-69% -$118K ﹤0.01% 601
2024
Q2 		$171K Sell
61,066
-4,139
-6% -$11.1K 0.01% 538
2024
Q1 		$185K Buy
65,205
+36,253
+125% +$123K 0.01% 562
2023
Q4 		$118K Buy
28,952
+9,204
+47% +$25.8K 0.01% 695
2023
Q3 		$62.8K Buy
+19,748
New +$62.8K 0.01% 743

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winton Group's ORGO Position: Q4 2024 in Review

Winton Group sold out of Organogenesis Holdings (ORGO) in Q4 2024, closing a stake of 18,945 shares — an estimated $54.2K sold.

Winton Group first reported a position in ORGO in Q3 2023 and held it in 5 quarters. The position peaked at $185K in Q1 2024. 120 funds tracked by Wall St. Rank hold ORGO as of Q4 2024.

  • Winton Group reported no remaining Organogenesis Holdings position as of Q4 2024 after selling out during the quarter.
  • Winton Group sold 18,945 Organogenesis Holdings shares in Q4 2024, an estimated $54.2K.
  • Winton Group first reported a position in Organogenesis Holdings in Q3 2023 and held it in 5 quarters.
  • Winton Group's Organogenesis Holdings position peaked at $185K in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2024.

Based on Winton Group's 13F filing for Q4 2024, filed 12 Feb 2025.